CBDLCBD Life Sciences Inc.
The schedule
- Thu15Oct
Potential equity offering could impact capital structure and investor sentiment.
- Fri27Nov
Earnings report and guidance for Q1 2026, with potential implications for future capital structure and strategic direction.
- Mon15Feb
Potential capital restructuring or restructuring announcement could impact financial leverage and operational flexibility.
- Fri28May
- Fri27Aug
Earnings report and guidance for Q4 2026, with potential implications for future capital structure and strategic direction.
Past
- Fri28Aug
Actual outcome: Mixed · $0.00 at outcome
The company reported an EPS actual of 0 vs an estimate of 0, resulting in a beat. However, the stock remained flat due to lack of clear directional catalysts or guidance, with no material price movement to confirm a bull or bear outcome.
Upcoming Q2 2026 financial results evaluating revenue stability and cash burn, anchored at a base price of $0.0002.